Navigation Links
Vion Pharmaceuticals Reports 2009 Second Quarter And Six-Month Results
Date:8/11/2009

NEW HAVEN, Conn., Aug. 11 /PRNewswire-FirstCall/ -- VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION) today announced financial results for the three-month and six-month periods ending June 30, 2009.

For the second quarter of 2009, the Company reported a net loss of $6.6 million, or $0.83 per share compared with a net loss of $7.9 million, or $1.06 per share, for the same 2008 period. Weighted-average common shares outstanding for the three months ended June 30, 2009 and June 30, 2008 were 8.0 million and 7.4 million, respectively.

For the six-month period, the net loss was $10.9 million, or $1.37 per share, compared with a net loss of $16.1 million, or $2.20 per share, for the same 2008 period. Weighted-average common shares outstanding for the six months ended June 30, 2009 and June 30, 2008 were 8.0 million and 7.3 million, respectively.

The Company will make a presentation on its lead oncology therapeutic Onrigin (laromustine) Injection to the Oncologic Drugs Advisory Committee (ODAC) of the U.S. Food and Drug Administration (FDA) on September 1, 2009. The ODAC reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of cancer and makes appropriate recommendations to the FDA. In February 2009, the Company submitted a New Drug Application (NDA) to the FDA for Onrigin as remission induction treatment for patients sixty years of age or older with de novo poor-risk acute myeloid leukemia (AML). In April 2009, the Company announced that the FDA had accepted the NDA for review and that it had been assigned an end user fee date of December 12, 2009 for a decision on approval by the FDA.

Alan Kessman, Chief Executive Officer, commented, "This is an exciting time for our Company. We are preparing for the ODAC meeting at the beginning of September and
'/>"/>

SOURCE Vion Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2013)... May 18 (HealthDay News) -- Just a few extra ... development of an autoimmune liver disease known as primary ... from the Mayo Clinic in Rochester, Minn., found that ... developing the disease, which can lead to cirrhosis of ... however, does not prove a cause-and-effect relationship. ...
(Date:5/18/2013)... 2013 In a May 14, 2013 ... Mastectomy After Discovering Cancer Gene,” Fox News reported the ... learning that she carried a gene that doctors estimated ... and a 50 percent risk of ovarian cancer (go ... May 16, 2013 with a blog post entitled “A ...
(Date:5/18/2013)... FL (PRWEB) May 18, 2013 The ... to the special places we call home. These are the ... maps. They are the locations where the people are friendly ... show takes viewers off the highways and shares the best ... of both nations with an American sports and film celebrity. ...
(Date:5/18/2013)... Family Magazine of Washington DC was awarded the "Best ... Inc. in the category of Summer Camps in DC ... the areas best in the ultimate guide on parenting, kids ... Brenda Hyde, a mother of four and publisher of Family ... vast resources available to them in the DC Metro area. ...
(Date:5/18/2013)... 18, 2013 The “Sleep Apnea Diagnostic ... CPAP, Masks, Adaptive Servo-Ventilation (ASV), Oral Appliances, Nasal EPAP, ... 2017” analyzes and studies the major market drivers, restraints, ... of the World. , Browse , ... 16 Figures , 318 pagesand in-depth ...
Breaking Medicine News(10 mins):Health News:Study Links Coffee to Lower Risk for Rare Liver Disease 2Health News:Angelina Jolie – Scarless Breast Augmentation Surgery 2Health News:Communities of Distinction TV Presents "A Place to Call Home" Segment 2Health News:Summer Camps in DC "Best of the Best" Awarded to Family Magazine of Washington DC for Excellence by Follow Media Consulting, Inc. 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3
... recognition system are nearly six times more likely to ... transcription, a new study in Canada shows. The ... multidisciplinary team rounds: 308 reports generated with automatic ... immediately transcribes the report on a computer screen) and ...
... asthma (STRA) may have poorer lung function and worse ... lower levels of vitamin D in their blood, according ... may cause structural changes in the airway muscles of ... provides important new evidence for possible treatments for the ...
... Reporter , THURSDAY, Sept. 22 (HealthDay News) -- From hide-and-seek ... of the hallmarks of childhood. But in this era of ... have far less time to play than kids of ... for their development and mental health. "Into the 1950s, ...
... for simultaneously visualizing gene number and protein expression in ... detailed analysis of the relationship between gene status and ... and bring a clearer understanding of cancer and other ... The new technique is called the fluorescent in situ ...
... Reporter , WEDNESDAY, Sept. 21 (HealthDay News) -- Waiting ... risk of death and hospitalization in people with kidney ... to die or head to the hospital for cardiovascular-related ... sessions compared to a one-day gap, concluded researchers from ...
... Reporter , WEDNESDAY, Sept. 21 (HealthDay News) -- With plenty ... to get a flu shot. Last year, some 130.9 ... got a shot, which represents an increase over past years. ... years old. But, more adults are getting vaccinated, too, according ...
Cached Medicine News:Health News:Error rate higher in breast imaging reports generated by automatic speech recognition 2Health News:Vitamin D deficiency linked with airway changes in children with severe asthma 2Health News:Vitamin D deficiency linked with airway changes in children with severe asthma 3Health News:Less Play Time = More Troubled Kids, Experts Say 2Health News:Less Play Time = More Troubled Kids, Experts Say 3Health News:Novel technique reveals both gene number and protein expression simultaneously 2Health News:Two-Day Dialysis Interval Could Pose Danger: Study 2Health News:Two-Day Dialysis Interval Could Pose Danger: Study 3Health News:CDC Urges Americans: Get Your Flu Shot 2Health News:CDC Urges Americans: Get Your Flu Shot 3
(Date:5/17/2013)... CHAPEL HILL, N.C. , May 17, 2013 ... on how organizations communicate internally. Faced with a ... adjust their strategies and tactics for communicating with ... the effectiveness of all the strategies, tactics and ... In a new study, Best ...
(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- United Medical ... Cardiac Life Support (ACLS), Pediatric Advanced Life Support (PALS) ... PALS, BLS and ACLS online course manuals. ... people simply need to build an account with the ... for these programs, United Medical Education is setting a ...
(Date:5/17/2013)... 2013 /PRNewswire-iReach/ -- The escalation of new biological ... renewed emphasis on alternate delivery technologies. Alternate delivery ... of factors are converging to create both ... delivery device partners . These include new classes ... trend toward self-administration for chronic diseases, shifting patient ...
Breaking Medicine Technology:Internal Communication Strategies and Tactics that Resonate with Key Stakeholders and Drive Organizational Effectiveness 2ACLS Online Course Manuals are Now Available at No Cost through United Medical Education 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3
Large, bright images from a bronchoscope designed for routine examination and treatment....
... High performance fiberoptic imaging from the ... has improved its fiberscope range, focussing ... and enhanced image performance. Olympus has ... for diagnosis and therapy in the ...
Facilitates one-lung ventilation when using dual lumen endobronchial tubes....
... Silbroncho is a double lumen tube made of ... tip., ,Due to the characteristics of silicone ... the patient at insertion. Furthermore, the tube will ... suitable for long term surgery., ,Silbronco is ...
Medicine Products: